ACM
CTMX icon

ADAR1 Capital Management’s CytomX Therapeutics CTMX Stock Holding History

ADAR1 Capital Management’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16M Sell
3,410,190
-772,579
-18% -$3.92M 0.96% 21
2025
Q4 		$17.8M Buy
4,182,769
+137,355
+3% +$522K 1.33% 13
2025
Q3 		$12.9M Buy
4,045,414
+964,000
+31% +$2.17M 1.28% 17
2025
Q2 		$6.99M Buy
3,081,414
+3,034,378
+6,451% +$4.89M 1.14% 24
2025
Q1 		$29.9K Sell
47,036
-98,000
-68% -$76K 0.01% 188
2024
Q4 		$149K Sell
145,036
-758,923
-84% -$816K 0.03% 169
2024
Q3 		$1.07M Buy
903,959
+331,789
+58% +$421K 0.18% 69
2024
Q2 		$698K Buy
572,170
+417,170
+269% +$830K 0.14% 81
2024
Q1 		$338K Buy
+155,000
New +$286K 0.09% 98

Other funds holding CTMX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return